Agenus Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Agenus Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 16% in 3 years; of every extra $100 of sales, $1,362 became extra profit. Higher than 98% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-43.6×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 70% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$1,362Sales grew 16% in 3 years; of every extra $100 of sales, $1,362 became extra profit.
Higher than 98% of Healthcare companies in United States.
Asset Productivity Ratio
+16% / -45%In 3 years sales changed by +16% while total assets changed by -45%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-1.7×Operating cash was negative last year, while some debt falls due within a year.
Higher than 65% of Healthcare companies in United States.
Cash Cushion Ratio
−18%Debt, after subtracting cash, equals 18% of its market value (net debt).
Lower than 83% of Healthcare companies in United States.
Tangible Assets Ratio
88%Of every $100 the company owns, $88 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 59% of Healthcare companies in United States.
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Agenus Inc. owes $2.19 for every $1 it owns. Agenus Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
2.6Investors pay $2.6 for every $1 of Agenus Inc.'s yearly profit, lower than 89% of Healthcare companies in United States.
P/B ratio
-1.48Agenus Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$294 MThe total market value of all of Agenus Inc.'s shares at today's price (share price × number of shares), smaller than 52% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
NegativeAgenus Inc.'s net worth is negative ($199 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
2.19×Agenus Inc. owes $2.19 for every $1 it owns, so it owes more than it owns, higher than 96% of Healthcare companies in United States.
Dividend yield
NoneAgenus Inc. does not currently pay a dividend.
Revenue growth
+10%Revenue rose 10% in the year to Dec 2025, and grew 5% a year on average over 3 years.
Profit growth
Back to profitAgenus Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Profit margin
0.1%Agenus Inc. keeps $0 of every $100 of revenue as net profit.
Cash quality
-671.3×Cash from Agenus Inc.'s business was -671.3× its reported profit in the year to Dec 2025 — the business used cash even though it reported a profit.
Interest cover
Not coveredAgenus Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtAgenus Inc. had $53 M more debt than cash (net debt) at Dec 2025.
Questions
What is Agenus Inc.'s P/E ratio?
Investors pay $2.6 for every $1 of Agenus Inc.'s yearly profit, lower than 89% of Healthcare companies in United States.
How much does Agenus Inc. owe compared with what it owns?
Agenus Inc. owes $2.19 for every $1 it owns, so it owes more than it owns, higher than 96% of Healthcare companies in United States.
Does Agenus Inc. pay a dividend?
No. Agenus Inc. does not currently pay a dividend.
Is Agenus Inc.'s revenue growing?
Revenue rose 10% in the year to Dec 2025, and grew 5% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.